Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers

COVID Clinical Trial

Official title:

Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers: Cross Sectional Study on Turkish Society and Interpretation With Physical Activity Level

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04412278
• Other study ID #: 500600127
• Status: Completed
• Start date: June 1, 2020
• Est. completion date: June 8, 2020

Study information

• Verified date: June 2020
• Source: Okan University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

It is aimed to determine the physical activity level and exercise benefits and barriers caused by Covid-19 pandemic and reveal the relationship between them.

Description:

Study hypothesis that people are tend to be physically inactive while Covid-19 pandemic. It is aimed to determine the exercise benefits and barriers caused by Covid-19 pandemic and reveal the relationship among gender, age, marial status and physical activity level.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 392
• Est. completion date: June 8, 2020
• Est. primary completion date: June 8, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 15 Years to 65 Years

Eligibility

Inclusion Criteria:

• being Turkish

• understanding Turkish

• being between the age of 15 - 65

• being literate

• have internet access

Exclusion Criteria:

• having a disable condition to exercise

• having missing value on outcome measures

• giving incomprehensible answering

Related Conditions & MeSH terms

• COVID
• Isolation, Social

Intervention

Other:
• Online Survey
Volunteer individuals enrolled the study after approval an online informed consent form. Sociodemographic data of the participants recorded as an online survey. Then, patient reported outcomes were used to assess physical activity level (International Physical Actvity Questionairre) and Exercise Benefits and Barriers (Exercise Benefits and Barriers Scale).

Locations

Country	Name	City	State
Turkey	Istanbul Okan University	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Okan University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Exercise Benefits and Barriers Scale	The Exercise Benefits/Barriers Scale (EBBS) was developed in response to a need for an instrument to determine perceptions of individuals concerning the benefits of and barriers to participating in exercise. The instrument may be scored and used in its entirety or as two separate scales. The instrument has a four-response, forced-choice Likert-type format with responses ranging from 4 (strongly agree) to 1 (strongly disagree). Scores on the total instrument can range from 43 to 172. The higher the score, the more positively the individual perceives exercise. When the Benefits Scale is used alone, the score range is between 29 and 116. When the Barriers Scale is used alone, scores range between 14 and 56. If used alone, the Barriers Scale does not need to be reverse-scored. In this instance, the higher the score on the Barriers Scale, the greater the perception of barriers to exercise.	three months after Covid 19 recognised as pandemic
Primary	Sociodemographic information	Participants will be asked to give information about: age, gender, educational status, height, weight, occupation, working status, whether they have a chronic disease.	three months after Covid 19 recognised as pandemic
Secondary	International Physical Activity Questionairre	The IPAQ-S developed for participants to report activities performed for at least 10 minutes during the last 7 days. Respondents will be asked to report time spent in physical activity performed across leisure time, work, domestic activities, and transport at each of 3 intensities: walking, moderate, and vigorous. Using the instrument's scoring protocol total weekly physical activity was estimated by weighting time spent in each activity intensity with its estimated metabolic equivalent (MET) energy expenditure. The IPAQ scoring protocol assigns the following MET values to walking, moderate, and vigorous intensity activity: 3.3 METs, 4.0 METs, and 8.0 METs, respectively. Participants will be considered to have met American Collage of Sports Medicine physical activity recommendations. if they reported at least 150 min/wk of walking, moderate, or vigorous intensity physical activity.	three months after Covid 19 recognised as pandemic